Sterling Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.47K Buy
499
+276
+124% +$2.47K ﹤0.01% 2571
2025
Q1
$1.67K Buy
223
+13
+6% +$98 ﹤0.01% 2654
2024
Q4
$1.58K Hold
210
﹤0.01% 2842
2024
Q3
$1.6K Buy
+210
New +$1.6K ﹤0.01% 2302